Literature DB >> 5694511

Low-temperature-grown RS virus in adult volunteers.

W T Friedewald, B R Forsyth, C B Smith, M A Gharpure, R M Chanock.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 5694511

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  35 in total

1.  The major attenuating mutations of the respiratory syncytial virus vaccine candidate cpts530/1009 specify temperature-sensitive defects in transcription and replication and a non-temperature-sensitive alteration in mRNA termination.

Authors:  K Juhasz; B R Murphy; P L Collins
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 2.  Current research on respiratory viral infections: Third International Symposium.

Authors:  A C Schmidt; R B Couch; G J Galasso; F G Hayden; J Mills; B R Murphy; R M Chanock
Journal:  Antiviral Res       Date:  2001-06       Impact factor: 5.970

3.  The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein.

Authors:  K Juhasz; S S Whitehead; P T Bui; J M Biggs; J E Crowe; C A Boulanger; P L Collins; B R Murphy
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees.

Authors:  S S Whitehead; K Juhasz; C Y Firestone; P L Collins; B R Murphy
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Acquisition of the ts phenotype by a chemically mutagenized cold-passaged human respiratory syncytial virus vaccine candidate results from the acquisition of a single mutation in the polymerase (L) gene.

Authors:  J E Crowe; C Y Firestone; S S Whitehead; P L Collins; B R Murphy
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

6.  Temperature-sensitive mutants of respiratory syncytial virus.

Authors:  M A Gharpure; P F Wright; R M Chanock
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

Review 7.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1969-07       Impact factor: 2.401

8.  Live influenza virus vaccines.

Authors: 
Journal:  Br Med J       Date:  1969-06-21

9.  Live-attenuated respiratory syncytial virus vaccines.

Authors:  Ruth A Karron; Ursula J Buchholz; Peter L Collins
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro.

Authors:  Matthew B Elliott; Karin S Pryharski; Qingzhong Yu; Christopher L Parks; Todd S Laughlin; C Kanta Gupta; Robert A Lerch; Valerie B Randolph; Natisha A LaPierre; Kristen M Heers Dack; Gerald E Hancock
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.